Lawrence Hineline - Intra Cellular Insider

Intra Cellular Therapies Inc -- USA Stock  

USD 16.08  0.01  0.0622%

Vice President and CFO

Mr. Lawrence J. Hineline, CPA, is Chief Financial Officer, Vice President Finance, Treasurer, Assistant Secretary of IntraCellular Therapies, Inc. Mr. Hineline also served as the Secretary of the Company from August 2013 until September 2014. From December 2000 to November 2003, Mr. Hineline was the Vice President of Finance and Chief Financial Officer of Functional Genetics, Inc. Prior to that, Mr. Hineline served as the Vice President of Finance of North American Vaccine, Inc. and its predecessor companies from 1993 to 2000, and he served as Corporationrationrate Controller from 1989 to 1993. During this time, Mr. Hineline oversaw the growth of the accounting function and its systems for the company that emerged as a startup and was later acquired by Baxter Health Care
Age: 59  President Since 2014  CPA    
212 923-3344
Hineline is a licensed CPA in the State of Maryland and received his Bachelor?s Degree from the University of Maryland Baltimore County.

Management Efficiency

The company has return on total asset (ROA) of (16.4) % which means that it has lost $16.4 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (26.76) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

IntraCellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system . Intra Cellular Therapies Inc (ITCI) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 37 people. Intra Cellular is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio File Import Now

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
Hide  View All  Next  Launch Portfolio File Import
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Intra Cellular Therapies Inc to your portfolio

Top Management

Intra Cellular Thera Leadership Team
Lawrence Wennogle, President, Ph.D
Christopher Alafi, Director
Michael Rawlins, Director
Robert Nostrand, Director
Richard Lerner, Director
Robert Davis, President, Ph.D
Allen Fienberg, Founder, Ph.D
Michael Halstead, SVP
Sharon Mates, Chairman, Ph.D
Juan Sanchez, President
Rory Riggs, Director, MBA
Joel Marcus, Director
Kimberly Vanover, VP, Ph.D
Lawrence Hineline, President, CPA

Stock Performance

Intra Cellular Performance Indicators